{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:46:39Z","timestamp":1780361199740,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05672-5","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T03:02:23Z","timestamp":1708398143000},"page":"2419-2427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["2-[18]F FDG PET\/CT dissemination features in adult burkitt lymphoma Are predictive of outcome"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-6494","authenticated-orcid":false,"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Talin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-9033","authenticated-orcid":false,"given":"Francesco","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6962-4466","authenticated-orcid":false,"given":"Chiara","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-7463","authenticated-orcid":false,"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9808-780X","authenticated-orcid":false,"given":"Giorgio","family":"Treglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2980-5964","authenticated-orcid":false,"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"5672_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR (2016) 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 66:443\u2013459","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"5672_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMra2025746","volume":"387","author":"M Roschewski","year":"2022","unstructured":"Roschewski M, Staudt LM, Wilson WH (2022) Burkitt\u2019s lymphoma. N Engl J Med 387(12):1111\u20131122. https:\/\/doi.org\/10.1056\/NEJMra2025746","journal-title":"N Engl J Med"},{"issue":"7418","key":"5672_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M et al (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116\u2013120. https:\/\/doi.org\/10.1038\/nature11378","journal-title":"Nature"},{"issue":"12","key":"5672_CR4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","volume":"133","author":"BM Grande","year":"2019","unstructured":"Grande BM, Gerhard DS, Jiang A et al (2019) Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood 133(12):1313\u20131324. https:\/\/doi.org\/10.1182\/blood-2018-09-871418","journal-title":"Blood"},{"issue":"6","key":"5672_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1182\/blood.2019004099","volume":"137","author":"J Crombie","year":"2021","unstructured":"Crombie J, LaCasce A (2021) The treatment of Burkitt lymphoma in adults. Blood 137(6):743\u2013750. https:\/\/doi.org\/10.1182\/blood.2019004099","journal-title":"Blood"},{"issue":"1","key":"5672_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","volume":"8","author":"C L\u00f3pez","year":"2022","unstructured":"L\u00f3pez C, Burkhardt B, Chan JKC et al (2022) Nat Rev Dis Primers 8(1):78. https:\/\/doi.org\/10.1038\/s41572-022-00404-3","journal-title":"Nat Rev Dis Primers"},{"key":"5672_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40336-020-00356-2","volume":"8","author":"D Albano","year":"2020","unstructured":"Albano D, Bertagna F, Giubbini (2020) R.18F-FDG PET\/CT role in Burkitt lymphoma. Clin Transl Imaging 8:39\u201345","journal-title":"Clin Transl Imaging"},{"key":"5672_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/apc.2008.0174","volume":"22","author":"PA Just","year":"2008","unstructured":"Just PA, Fieschi C, Baillet G et al (2008) 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in AIDS-related Burkitt lymphoma. AIDS Patient Care STDS 22:695\u2013700","journal-title":"AIDS Patient Care STDS"},{"key":"5672_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/RLU.0b013e3181a34552","volume":"4","author":"W Zeng","year":"2009","unstructured":"Zeng W, Lechowicz MJ, Winton E et al (2009) Spectrum of FDG PET\/CT findings in Burkitt lymphoma. Clin Nucl Med 4:355\u2013358","journal-title":"Clin Nucl Med"},{"key":"5672_CR10","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2012","unstructured":"Karantanis D, Durski JM, Lowe VJ et al (2012) 18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma. Eur J Radiol 75:e68\u201373","journal-title":"Eur J Radiol"},{"key":"5672_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ejh.12284","volume":"94","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Rodr\u0131guez MS, Borrego-Dorado I et al (2015) Role of 18F-FDG-PET\/CT in the management of Burkitt lymphoma. Eur J Haematol 94:23\u201330","journal-title":"Eur J Haematol"},{"key":"5672_CR12","first-page":"1","volume":"3","author":"D Albano","year":"2018","unstructured":"Albano D, Bosio G, Re A et al (2018) Metabolic behaviour and prognostic value of early and end of treatment 18F-FDG PET\/CT in adult Burkitt lymphoma: role of Deauville and IHP criteria. Leuk Lymphoma 3:1\u20138","journal-title":"Leuk Lymphoma"},{"issue":"34","key":"5672_CR13","first-page":"608","volume":"2","author":"WX Wei","year":"2015","unstructured":"Wei WX, Huang JJ, Li WY et al (2015) Prognostic values of interim and post-therapy 18F-FDG PET\/CT scanning in adult patients with Burkitt\u2019s lymphoma. Chin J Cancer 2(34):608\u2013613","journal-title":"Chin J Cancer"},{"key":"5672_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00259-018-4173-2","volume":"46","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Pagani C et al (2019) Prognostic role of baseline 18F-FDG PET\/CT metabolic parameters in Burkitt lymphoma. Eur J Nucl Med Mol Imaging 46:87\u201396","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5672_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2967\/jnumed.119.229450","volume":"61","author":"AS Cottereau","year":"2020","unstructured":"Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O, Meignan M, Buvat I (2020) 18F-FDG PET dissemination features in diffuse large B-Cell lymphoma are Predictive of Outcome. J Nucl Med 61(1):40\u201345. https:\/\/doi.org\/10.2967\/jnumed.119.229450","journal-title":"J Nucl Med"},{"key":"5672_CR16","doi-asserted-by":"publisher","unstructured":"Albano D, Treglia G, Dondi F, Calabr\u00f2 A, Rizzo A, Annunziata S, Guerra L, Morbelli S, Tucci A, Bertagna F (2023) 18F-FDG PET\/CT maximum tumor dissemination (Dmax) in lymphoma: a New Prognostic factor? Cancers (Basel). 15(9):2494. https:\/\/doi.org\/10.3390\/cancers15092494","DOI":"10.3390\/cancers15092494"},{"key":"5672_CR17","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","volume":"124","author":"D Hoelzer","year":"2014","unstructured":"Hoelzer D, Walewski J, D\u00f6hner H, Viardot A, Hiddemann W, Spiekermann K et al (2014) Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 124:3870\u20133879","journal-title":"Blood"},{"key":"5672_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bjh.12020","volume":"159","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Bruno VM, Donadoni G, Cattaneo C, Fumagalli L, Foppoli M et al (2012) Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma. Br J Haematol 159:252\u2013255","journal-title":"Br J Haematol"},{"issue":"2","key":"5672_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJG et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imag 42(2):328\u2013354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"27","key":"5672_CR20","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/jco.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the lugano classification. J Clin Oncol 32(27):3059\u20133067. https:\/\/doi.org\/10.1200\/jco.2013.54.8800","journal-title":"J Clin Oncol"},{"key":"5672_CR21","doi-asserted-by":"crossref","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, M\u00fceller SP et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol. ;32:3048\u201358","DOI":"10.1200\/JCO.2013.53.5229"},{"issue":"16","key":"5672_CR22","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78(16):4786\u20134789. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0125","journal-title":"Cancer Res"},{"key":"5672_CR23","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","volume":"17","author":"D Dubois","year":"1916","unstructured":"Dubois D, Dubois EF (1916) A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 17:863\u2013871","journal-title":"Arch Intern Med"},{"issue":"10","key":"5672_CR24","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1007\/s00259-021-05233-2","volume":"48","author":"R Frood","year":"2021","unstructured":"Frood R, Burton C, Tsoumpas C, Frangi AF, Gleeson F, Patel C, Scarsbrook A (2021) Baseline PET\/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review. Eur J Nucl Med Mol Imaging 48(10):3198\u20133220. https:\/\/doi.org\/10.1007\/s00259-021-05233-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"5672_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/hon.3025","volume":"40","author":"R Durmo","year":"2022","unstructured":"Durmo R, Donati B, Rebaud L, Cottereau AS, Ruffini A, Nizzoli ME, Ciavarella S, Vegliante MC, Nioche C, Meignan M, Merli F, Versari A, Ciarrocchi A, Buvat I, Luminari S (2022) Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: a radio-genomic study. Hematol Oncol 40(4):645\u2013657. https:\/\/doi.org\/10.1002\/hon.3025","journal-title":"Hematol Oncol"},{"issue":"3","key":"5672_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","volume":"32","author":"AS Cottereau","year":"2021","unstructured":"Cottereau AS, Meignan M, Nioche C, Capobianco N, Clerc J, Chartier L, Vercellino L, Casasnovas O, Thieblemont C, Buvat I (2021) Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT. Ann Oncol 32(3):404\u2013411. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.019","journal-title":"Ann Oncol"},{"issue":"1","key":"5672_CR27","first-page":"54","volume":"16","author":"C Bailly","year":"2014","unstructured":"Bailly C, Eug\u00e8ne T, Couec ML, StrulluM, Frampas E, Campion L et al (2014) Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy. Front Med (Lausanne) 16(1):54","journal-title":"Front Med (Lausanne)"},{"issue":"34","key":"5672_CR28","first-page":"608","volume":"2","author":"WX Wen","year":"2015","unstructured":"Wen WX, Huang JJ, Li WY, Zhang X, Xia Y, Jiang WQ et al (2015) Prognostic values of interim and post-therapy 18F-FDG PET\/CT scanning in adult patients with Burkitt\u2019s lymphoma. Chin J Cancer 2(34):608\u2013613","journal-title":"Chin J Cancer"},{"key":"5672_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/RLU.0b013e3181a34552","volume":"4","author":"W Zeng","year":"2009","unstructured":"Zeng W, Lechowicz MJ, Winton E, Cho SM, Galt JR, Halkar R (2009) Spectrum of FDG PET\/CT findings in Burkitt lymphoma. Clin Nucl Med 4:355\u2013358","journal-title":"Clin Nucl Med"},{"key":"5672_CR30","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ejrad.2009.07.035","volume":"75","author":"D Karantanis","year":"2012","unstructured":"Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E et al (2012) 18F-FDG PET and PET\/CT in Burkitt\u2019s lymphoma. Eur J Radiol 75:e68\u201373","journal-title":"Eur J Radiol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05672-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05672-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T16:03:41Z","timestamp":1720109021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05672-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5672"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05672-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"28 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical review and approval were waived for this study (observational retrospective) due to the retrospective design of the study, according to local laws.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}